South Korean biopharmaceutical company Celltrion said it would invest at least $1 billion to acquire a plant from Eli Lilly in the United States and upgrade it. Celltrion vows to invest $1 billion to buy, upgrade U.S. Lilly plant
1 year ago
134
South Korean biopharmaceutical company Celltrion said it would invest at least $1 billion to acquire a plant from Eli Lilly in the United States and upgrade it. 
English (US) ·